Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Anaes SAQsCritical incidents & patient safety

Anaes SAQs · Critical incidents & patient safety

Rising end-tidal carbon dioxide on sevoflurane — the MH crisis bundle

Final SAQ on malignant hyperthermia: the sentinel end-tidal carbon dioxide, the absolute trigger list, the dantrolene dosing spine, cooling and hyperkalaemia management, and the trigger-free plan with family referral.

10 marks10 min2 min readSource-verified ·

Target exams

ANZCAFRCAABAEDAICFCAIFCA_SA
On this page
Study tools

Target exams

ANZCAFRCAABAEDAICFCAIFCA_SA
Prompt
Forty minutes into a sevoflurane anaesthetic, the end-tidal carbon dioxide climbs from 4.5 to 9 kPa despite a doubling of the minute ventilation. The heart rate is 140, the jaw was tight after suxamethonium at induction, and the temperature reads 38.4 degrees and rising. Outline your diagnosis and crisis management.

Question

Forty minutes into a sevoflurane anaesthetic, the end-tidal carbon dioxide climbs from 4.5 to 9 kPa despite a doubling of the minute ventilation. The heart rate is 140, the jaw was tight after suxamethonium at induction, and the temperature reads 38.4 degrees and rising. Outline your diagnosis and crisis management[1][2].

Anaesthesia Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Anaesthesia fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Glahn KPE, Girard T, Hellblom A, et al. Recognition and management of a malignant hyperthermia crisis: updated 2024 guideline from the European Malignant Hyperthermia Group Br J Anaesth, 2025.PMID 39482150
  2. [2]Larach MG, Gronert GA, Allen GC, et al. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006 Anesth Analg, 2010.PMID 20081135
  3. [3]Rosenberg H, Pollock N, Schiemann A, et al. Malignant hyperthermia: a review Orphanet J Rare Dis, 2015.PMID 26238698
  4. [4]Krause T, Gerbershagen MU, Fiege M, et al. Dantrolene--a review of its pharmacology, therapeutic use and new developments Anaesthesia, 2004.PMID 15023108
  5. [5]Rüffert H, Bastian B, Bendixen D, et al. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group Br J Anaesth, 2021.PMID 33131754
Anaesthesia Pro

$29/ monthor $279 / year

The complete Anaesthesia library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousCollapse after an induction drug — recognition and adrenalineCritical incidents & patient safetyNextVomiting on induction for bowel obstruction — RSI and the SOILED bundleCritical incidents & patient safety